Parker Hannifin
PH
$965.88
+1.09%
Parker-Hannifin Corporation is a global industrial machinery manufacturer that engineers and sells motion and control technologies, including hydraulic, pneumatic, electromechanical, climate control, and filtration components, into aerospace, industrial automation, off-highway, and transportation end markets. The company is a diversified industrial compounder and one of the most respected operators in its sector, distinguished by a portfolio of branded, highly engineered components that are often designed to work together, driving a high rate of cross-selling and sticky aftermarket revenue. The current investor narrative centers on Parker's transformation into a higher-margin, less cyclical enterprise, anchored by its Aerospace Systems segment, which generated $1.706 billion of revenue in the most recent quarter versus $3.468 billion from the Diversified Industrial segment. Management's disciplined capital deployment — highlighted by the announced acquisition of CIRCOR's commercial and defense aerospace business, which is expected to immediately boost growth, margins, and earnings — alongside aggressive share repurchases and a long-running margin expansion program, has kept the stock in favor despite a recent pullback from all-time highs.…
PH
Parker Hannifin
$965.88
Related headlines
Investment Opinion: Should I buy PH Today?
The synthesized recommendation is a Buy, anchored by the analyst consensus rating of 'buy' (mean 1.73) and an average target price of $1,158.41, implying 18.4% upside from the current price of $978.33. The core thesis is that Parker's transformation into a higher-margin, aerospace-weighted industrial compounder, coupled with the accretive CIRCOR acquisition and consistent margin expansion, justifies a premium valuation despite near-term momentum deceleration. The recent pullback of 5.88% over the past month offers an attractive entry point for long-term investors, as the fundamental growth story remains intact.
Supporting evidence includes: 1) Revenue growth of 10.6% YoY in Q3 2026, with sequential acceleration; 2) Net margin of 16.48% and operating margin of 21.55%, with EPS growing from $6.29 to $7.06 over three quarters; 3) Free cash flow of $3.678B TTM, comfortably covering the $227M quarterly dividend and $340M buybacks; 4) Return on equity of 23.69%, well above industrial norms; and 5) The CIRCOR acquisition expected to immediately boost growth, margins, and earnings. While the trailing PE of 33.86x is elevated versus peers, the forward PE of 24.84x reflects expected earnings growth, and the PEG ratio of 6.80 suggests the market is pricing in substantial future growth.
The biggest risks that could invalidate the thesis are: 1) A cyclical industrial downturn that pressures the Diversified Industrial segment; 2) Integration missteps with CIRCOR that fail to deliver expected synergies; and 3) Multiple compression if growth decelerates or interest rates rise. The rating would upgrade to a Strong Buy if the stock pulls back to the $900 level (implying a forward PE below 20x) while fundamentals remain intact, or downgrade to Hold if revenue growth falls below 5% or if operating margins contract below 20%. Relative to its history and peers, the stock appears overvalued on a trailing basis but fairly valued on a forward basis, assuming earnings growth materializes. The valuation verdict is that Parker is fairly valued to slightly overvalued, but the quality and growth trajectory justify a premium for long-term investors.
Sign up to view all
PH 12-Month Price Forecast
Parker-Hannifin presents a compelling growth story, with accelerating revenue, expanding margins, and strong cash flow, supported by a bullish analyst consensus. The CIRCOR acquisition is a strategic catalyst that should enhance aerospace exposure and earnings. However, the stock's premium valuation and recent momentum deceleration warrant caution, and the wide analyst target range reflects uncertainty. The base case (50% probability) targets $1,050-$1,158, implying 7-18% upside, while the bear case (20%) could see a 27-30% decline. I would upgrade to high confidence if the stock pulls back to $900 or if CIRCOR integration exceeds expectations; I would downgrade to neutral if revenue growth falls below 5% or if operating margins contract.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Parker Hannifin's 12-month outlook, with a consensus price target around $1155.29 and implied upside of +19.6% versus the current price.
Average Target
$1155.29
0 analysts
Implied Upside
+19.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$680 - $1358
Analyst target range
Coverage is deep and constructive, with 24 analysts covering Parker and a consensus recommendation of "buy" (recommendation mean of 1.73 on a 1-5 scale where 1 is Strong Buy). The average price target of $1,158.41 implies roughly 18.4% upside from the current price of $978.33, a bullish signal that stands in contrast to the stock's recent 5.88% one-month decline and suggests the sell-side views the pullback as a buying opportunity. Consensus revenue estimates of $29.59 billion and EPS estimates of $49.91 for the coming year underpin the constructive stance, and the recent institutional ratings flow shows no downgrades — Truist Securities reiterated Buy on July 2, 2026, Wells Fargo and JP Morgan maintained Overweight ratings in May 2026, and Citigroup reaffirmed Buy in April and May 2026, indicating stable to improving sentiment. The target range is unusually wide, spanning from a low of $680 to a high of $1,358 — a spread of $678, or roughly 99% of the low target — which signals significant disagreement about the company's trajectory. The high target of $1,358 implies roughly 38.8% upside and likely assumes successful CIRCOR integration, sustained aerospace aftermarket growth, continued margin expansion toward the high end of management's targets, and further multiple expansion; the low target of $680 implies roughly 30.5% downside and likely prices in a cyclical industrial downturn, aerospace order softness, margin compression, or multiple normalization toward historical averages. The wide dispersion, combined with the stock trading near the top of its historical valuation band, means position sizing and entry discipline matter: the consensus is bullish, but the range of outcomes is wide enough that investors should weigh the risk of multiple compression against the fundamental momentum in aerospace and the earnings accretion expected from the CIRCOR acquisition.
Bulls vs Bears: PH Investment Factors
The bull case currently has stronger evidence, driven by accelerating revenue growth (10.6% YoY), consistent margin expansion, robust free cash flow ($3.678B TTM), and a bullish analyst consensus with 18.4% upside to the average target. However, the bear case is not without merit: the stock trades at a significant premium to industrial peers (33.86x trailing PE vs. 12x-15x EV/EBITDA for peers), recent momentum has decelerated sharply (down 5.88% in one month), and the wide analyst target range ($680-$1,358) underscores uncertainty. The single most important tension is whether Parker can sustain its premium valuation through continued aerospace-driven growth and successful CIRCOR integration, or whether multiple compression will occur if growth decelerates or cyclical pressures emerge. This debate will likely be resolved by upcoming earnings and the pace of margin expansion.
Bullish
- Aerospace-driven revenue acceleration: Revenue grew 10.6% YoY to $5.486B in Q3 2026, with sequential acceleration from $5.084B to $5.174B to $5.486B. Aerospace Systems contributed $1.706B and is the primary growth engine, soon to be augmented by the CIRCOR acquisition.
- Consistent margin expansion and EPS growth: Net income rose from $808M in Q1 2026 to $845M in Q2 to $904M in Q3, while diluted EPS climbed from $6.29 to $6.60 to $7.06. Operating margin reached 21.55% and EBITDA margin 26.49%, demonstrating strong operating leverage.
- Strong cash generation and balance sheet: Trailing free cash flow is $3.678B, with Q3 2026 FCF of $881M on operating cash flow of $984M against just $103M capex. Debt-to-equity is a conservative 0.553 and the current ratio is 1.26, providing ample flexibility.
- Analyst consensus bullish with 18.4% upside: 24 analysts rate the stock a 'buy' (mean 1.73), with an average target of $1,158.41 implying 18.4% upside from $978.33. No downgrades were seen in recent months, and the high target of $1,358 implies 38.8% upside.
Bearish
- Premium valuation leaves little room for error: Trailing PE of 33.86x and EV/EBITDA of 26.50x are well above the 12x-15x typical for diversified industrial peers. The PEG ratio of 6.80 and P/B of 8.02 indicate the market is pricing in optimistic growth expectations.
- Recent momentum deceleration and underperformance: The stock is down 5.88% over the past month and up only 0.97% over three months, lagging the S&P 500's +0.69% and +5.81% respectively. Relative strength is -6.57 over one month and -4.84 over three months, signaling a loss of near-term momentum.
- Wide analyst target dispersion signals uncertainty: Targets range from $680 to $1,358, a spread of $678 or roughly 99% of the low target. The low target implies 30.5% downside, reflecting significant disagreement about the company's trajectory and potential cyclical risks.
- Elevated beta increases volatility risk: Beta of 1.123 means the stock is roughly 12% more volatile than the broader market. In a market downturn, this could amplify losses, and the max drawdown of -19.52% over the past 180 days illustrates the potential for sharp corrections.
PH Technical Analysis
Parker-Hannifin is in a sustained longer-term uptrend, with the shares up 31.31% over the past year versus a 17.22% gain for the S&P 500, a 14.09 percentage point outperformance. At a current price of $978.33, the stock is trading at roughly 68.3% of its 52-week range of $715.37 to $1,099.94, meaning it sits in the upper-middle portion of its annual band but remains about 11.1% below its 52-week high. That positioning suggests a stock with strong underlying momentum that has recently entered a consolidation phase rather than one that is either overextended at highs or deeply discounted at lows. Recent momentum has clearly decelerated and diverged from the longer-term trend: the shares are down 5.88% over the past month and up only 0.97% over three months, sharply lagging the S&P 500's +0.69% and +5.81% respective moves, producing relative strength readings of -6.57 and -4.84 over those windows. The 1-month decline against a +31.31% 1-year gain signals a meaningful mean-reversion pullback within an intact uptrend, and the stock's recovery from a September 16 low of $918.75 back to $978.33 over the subsequent seven sessions suggests buyers are stepping in near the $920 area. Key technical support sits at the 52-week low of $715.37, with intermediate support around the recent $918-$925 swing low, while resistance is defined by the 52-week high of $1,099.94 and the August 6 breakout level near $1,070. A decisive break above $1,100 would confirm trend continuation toward new highs, whereas a breakdown below $918 would threaten the medium-term uptrend and open the door to a test of the 52-week low. With a beta of 1.123, Parker is roughly 12% more volatile than the broader market, a moderate risk profile that warrants modestly smaller position sizing than an index-like exposure.
Beta
1.12
1.12x market volatility
Max Drawdown
-19.5%
Largest decline past year
52-Week Range
$715-$1100
Price range past year
Annual Return
+27.9%
Cumulative gain past year
| Period | PH Return | S&P 500 |
|---|---|---|
| 1m | +1.4% | +0.3% |
| 3m | +0.3% | +2.6% |
| 6m | +6.4% | +16.5% |
| 1y | +27.9% | +14.3% |
| ytd | +8.0% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PH Fundamental Analysis
Parker's revenue trajectory is firmly growing and has been re-accelerating: fiscal Q3 2026 (quarter ended March 31, 2026) revenue reached $5.486 billion, up 10.6% year over year, following $5.174 billion in Q2 2026 and $5.084 billion in Q1 2026, both of which also grew versus the prior-year periods. The sequential progression from $5.084 billion to $5.174 billion to $5.486 billion represents accelerating top-line momentum, and the segment mix shows Aerospace Systems contributing $1.706 billion alongside $3.468 billion from Diversified Industrial, with the aerospace business — soon to be augmented by the CIRCOR acquisition — acting as the primary growth engine. This combination of mid-single-digit organic growth plus aerospace-driven acceleration supports a re-rating case, particularly as the CIRCOR deal is expected to immediately boost growth, margins, and earnings. Profitability is robust and improving: Q3 2026 net income was $904 million on a 16.48% net margin, with a 36.77% gross margin and a 21.55% operating margin, while EBITDA of $1.453 billion equated to a 26.49% EBITDA margin. Gross margin has hovered in a tight 36.4%-37.5% band over the past several quarters, but net income has climbed from $808 million in Q1 2026 to $845 million in Q2 2026 to $904 million in Q3 2026, and diluted EPS rose from $6.29 to $6.60 to $7.06 over the same span — evidence of steady operating leverage and margin expansion. The balance sheet and cash generation are strong: debt-to-equity stands at a conservative 0.553, the current ratio is 1.26, and trailing free cash flow is $3.678 billion, with Q3 2026 free cash flow of $881 million on operating cash flow of $984 million against just $103 million of capital expenditure. Return on equity of 23.69% and return on assets of 9.79% are well above typical industrial machinery norms, and the company comfortably funds its $227 million quarterly dividend and $340 million of quarterly buybacks from internal cash flow, with a dividend payout ratio of only 25.65% and a dividend yield of 0.76%.
Quarterly Revenue
$5.8B
2026-06
Revenue YoY Growth
+9.8%
YoY Comparison
Gross Margin
39.0%
Latest Quarter
Free Cash Flow
$3.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PH Overvalued?
Because Parker is solidly profitable — Q3 2026 net income of $904 million and trailing EPS of $7.16 — the PE ratio is the appropriate primary valuation metric. The stock trades at a trailing PE of 33.86x versus a forward PE of 24.84x, a 26.6% compression that implies the market expects earnings to grow substantially over the next twelve months, consistent with consensus EPS estimates of $49.91 (which reflects the company's fiscal-year reporting convention and strong earnings power). The gap between trailing and forward multiples is a clear signal that investors are pricing in continued double-digit earnings growth rather than a maturing, low-growth industrial profile. Relative to the broader industrial machinery sector, Parker's 33.86x trailing PE and 5.75x price-to-sales ratio represent a meaningful premium, and its 26.50x EV/EBITDA is elevated versus the roughly 12x-15x typical for diversified industrial peers — a spread of roughly 75%-100% that is justified only in part by Parker's superior 23.69% ROE, 21.55% operating margin, and aerospace-weighted mix. The 6.80 PEG ratio and 8.02 price-to-book ratio further underscore that the market is paying up for quality and growth, and the 0.76% dividend yield is below the sector average, reflecting a growth-oriented rather than income-oriented shareholder base. Historically, Parker's PE has expanded dramatically: the trailing PE was 20.32x in the quarter ended March 2025, 24.09x in June 2025, and 29.66x in September 2025 before reaching 33.86x today, while the price-to-sales ratio has climbed from 15.78x in March 2025 to 20.59x in the most recent historical reading. This places the stock near the top of its multi-year valuation band, meaning the market is pricing in optimistic expectations for aerospace growth, CIRCOR synergies, and continued margin expansion — leaving limited room for execution missteps and elevating the risk of multiple compression if growth decelerates.
PE
33.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 18x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
26.5x
Enterprise Value Multiple
Investment Risk Disclosure
Parker's financial and operational risks are moderate but notable. The company carries a debt-to-equity of 0.553, which is manageable but not insignificant given the $99M quarterly interest expense. Revenue concentration in the Diversified Industrial segment ($3.468B in Q3 2026) exposes Parker to cyclical industrial demand, while the Aerospace segment ($1.706B) is the growth driver but also subject to defense budget cycles and airline capex trends. Gross margin has been range-bound between 36.4% and 37.5% over recent quarters, and any input cost inflation or supply chain disruption could pressure profitability. Additionally, the company's growth relies on continued acquisitions and share repurchases; a slowdown in M&A or a rise in integration costs could hinder earnings growth. The CIRCOR acquisition, while accretive, carries integration risk and could strain management bandwidth. Overall, Parker's financial risk is contained by strong cash flow ($3.678B TTM FCF) and a conservative payout ratio (25.65%), but the cyclical nature of its end markets remains a key vulnerability.
Market and competitive risks are significant given Parker's premium valuation. The stock trades at a trailing PE of 33.86x and EV/EBITDA of 26.50x, well above the 12x-15x typical for diversified industrial peers. This premium leaves little room for error; any earnings miss or guidance cut could trigger multiple compression. The beta of 1.123 indicates the stock is more volatile than the market, and in a rising interest rate environment, high-multiple industrials are particularly vulnerable to de-rating. Competitive threats include larger players like Eaton and Honeywell in aerospace and industrial components, as well as niche competitors in motion control. Regulatory risks are moderate, but defense aerospace exposure could be affected by changes in government spending. Recent news highlights the CIRCOR acquisition as a strategic positive, but if integration falters or if aerospace demand softens, the stock could face a sharp correction. Sector rotation away from industrials into other sectors could also pressure the shares.
In a worst-case scenario, a combination of a cyclical industrial downturn, aerospace order softness, and multiple compression could drive the stock down to its 52-week low of $715.37, representing a 26.9% decline from the current price of $978.33. The analyst low target of $680 implies a 30.5% downside, reflecting a scenario where earnings disappoint and the market re-rates the stock to historical average multiples. A more severe outcome could see the stock test the $680 level if CIRCOR integration fails, margins compress, and the broader market enters a recession. Given the max drawdown of -19.52% over the past 180 days, investors should be prepared for significant volatility. From the current price, a bear-case scenario could result in losses of 27% to 30%, with the $715-$680 range as a realistic downside target.
FAQ
The key risks include: 1) Valuation risk: the premium multiple (33.86x trailing PE) could compress if growth decelerates, potentially causing a 20-30% decline. 2) Cyclical risk: the Diversified Industrial segment ($3.468B in Q3 2026) is exposed to industrial downturns, which could pressure revenue and margins. 3) Integration risk: the CIRCOR acquisition may fail to deliver expected synergies, leading to earnings misses. 4) Macro risk: with a beta of 1.123, the stock is more volatile than the market, and rising interest rates could disproportionately impact high-multiple industrials. These risks are ranked from highest to lowest severity, with valuation and cyclical risks being the most immediate.
The 12-month forecast includes three scenarios: bull case (30% probability) targeting $1,158-$1,358, base case (50%) targeting $1,050-$1,158, and bear case (20%) targeting $680-$715. The base case is most likely, assuming steady revenue growth of 8-10% and EPS meeting consensus of $49.91, with the stock reaching the analyst average target of $1,158.41. The bull case requires successful CIRCOR integration and margin expansion, while the bear case assumes a cyclical downturn and multiple compression. The key assumption behind the base case is that Parker continues to execute on its margin expansion program and aerospace demand remains robust.
PH appears overvalued on a trailing basis but fairly valued on a forward basis. The trailing PE of 33.86x and EV/EBITDA of 26.50x are well above the 12x-15x typical for diversified industrial peers, and the PEG ratio of 6.80 suggests the market is pricing in significant future growth. However, the forward PE of 24.84x, based on consensus EPS of $49.91, reflects expected earnings growth and is more reasonable. The stock's historical PE has expanded from 20.32x in March 2025 to 33.86x today, placing it near the top of its multi-year valuation band. The market is paying a premium for Parker's superior ROE (23.69%) and aerospace-weighted mix, but this leaves limited room for execution missteps.
From a risk/reward perspective, PH is a good buy for long-term investors, with an average analyst target of $1,158.41 implying 18.4% upside from the current price of $978.33. The company's strong fundamentals, including 10.6% revenue growth, 21.55% operating margin, and $3.678B free cash flow, support the bullish case. However, the premium valuation (33.86x trailing PE) and recent 5.88% one-month decline introduce near-term risks. The biggest downside risk is a re-rating to the analyst low target of $680, representing 30.5% downside. For investors with a long-term horizon and tolerance for volatility, PH is a good buy, especially on pullbacks to the $900-$920 support zone.
PH is more suitable for long-term investment, given its strong fundamentals, consistent dividend (yield 0.76%), and growth trajectory. The company's beta of 1.123 indicates moderate volatility, and its earnings visibility is supported by long-term aerospace contracts and aftermarket revenue. Short-term trading could be risky due to the recent momentum deceleration and wide analyst target range. A suggested minimum holding period is 2-3 years to ride out cyclical fluctuations and benefit from the CIRCOR integration and margin expansion. The stock's history of outperformance (31.31% over one year vs. S&P 500's 17.22%) supports a buy-and-hold strategy for patient investors.